Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

NCT05240898 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT05240898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
August 26, 2021
Completion date
November 26, 2025
Enrollment
116 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors